Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by HAMELN PHARMA PLUS

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
021749 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
021751 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval